Accordingly, we assessed the prognostic value of MICAL-L2 in COAD using Kaplan–Meier survival analysis and found that patients with high MICAL-L2 expression have shorter OS and DSS compared with those with low MICAL-L2 expression. The gene discussed is MICALL2; the disease is colon adenocarcinoma.